rs12110022

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181675.4(PPP2R2B):​c.71-69712C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0598 in 152,172 control chromosomes in the GnomAD database, including 421 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.060 ( 421 hom., cov: 32)

Consequence

PPP2R2B
NM_181675.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.807

Publications

1 publications found
Variant links:
Genes affected
PPP2R2B (HGNC:9305): (protein phosphatase 2 regulatory subunit Bbeta) The product of this gene belongs to the phosphatase 2 regulatory subunit B family. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a beta isoform of the regulatory subunit B55 subfamily. Defects in this gene cause autosomal dominant spinocerebellar ataxia 12 (SCA12), a disease caused by degeneration of the cerebellum, sometimes involving the brainstem and spinal cord, and in resulting in poor coordination of speech and body movements. Multiple alternatively spliced variants, which encode different isoforms, have been identified for this gene. The 5' UTR of some of these variants includes a CAG trinucleotide repeat sequence (7-28 copies) that can be expanded to 55-78 copies in cases of SCA12. [provided by RefSeq, Jul 2016]
PPP2R2B Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 12
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181675.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP2R2B
NM_181675.4
MANE Select
c.71-69712C>T
intron
N/ANP_858061.3
PPP2R2B
NM_181674.3
c.269-69712C>T
intron
N/ANP_858060.2
PPP2R2B
NM_001271900.2
c.245-69712C>T
intron
N/ANP_001258829.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP2R2B
ENST00000394411.9
TSL:2 MANE Select
c.71-69712C>T
intron
N/AENSP00000377933.3
PPP2R2B
ENST00000394414.5
TSL:1
c.269-69712C>T
intron
N/AENSP00000377936.1
PPP2R2B
ENST00000394409.7
TSL:1
c.71-69712C>T
intron
N/AENSP00000377931.4

Frequencies

GnomAD3 genomes
AF:
0.0597
AC:
9080
AN:
152054
Hom.:
419
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.131
Gnomad AMI
AF:
0.0340
Gnomad AMR
AF:
0.0368
Gnomad ASJ
AF:
0.0513
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0387
Gnomad FIN
AF:
0.0260
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0334
Gnomad OTH
AF:
0.0584
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0598
AC:
9102
AN:
152172
Hom.:
421
Cov.:
32
AF XY:
0.0594
AC XY:
4419
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.131
AC:
5449
AN:
41494
American (AMR)
AF:
0.0367
AC:
561
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.0513
AC:
178
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.0383
AC:
185
AN:
4824
European-Finnish (FIN)
AF:
0.0260
AC:
276
AN:
10606
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0334
AC:
2274
AN:
68002
Other (OTH)
AF:
0.0578
AC:
122
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
422
844
1267
1689
2111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0479
Hom.:
100
Bravo
AF:
0.0635
Asia WGS
AF:
0.0200
AC:
69
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.1
DANN
Benign
0.19
PhyloP100
0.81
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12110022; hg19: chr5-146150417; API